wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39103567-ACEA3E13-D760-450F-9FA6-F9B454756F99
Q39103567-ACEA3E13-D760-450F-9FA6-F9B454756F99
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39103567-ACEA3E13-D760-450F-9FA6-F9B454756F99
VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma.
P2860
Q39103567-ACEA3E13-D760-450F-9FA6-F9B454756F99
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39103567-ACEA3E13-D760-450F-9FA6-F9B454756F99
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
744aad6f9d539cc1df7eef63bb7b4be2e1d14372
P2860
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.